IBT Staff Reporter

39421-39450 (out of 154943)

New York Times beats profit forecast; shares rise

New York Times Co reported a better-than-expected profit on Thursday as investors brushed past the company's drop in print and digital advertising revenue and focused more on the company's ability to manage costs.

Wall Street opens flat after labor data

Stocks opened flat on Thursday as a weak reading on the labor market and rumors of a French sovereign debt downgrade offset better-than-expected results from Bank of America and Morgan Stanley.

France, Spain clear bond auction hurdle

France and Spain sold all the bonds they wanted at auction on Thursday, though for Spain the cost was rising yields, indicating growing concerns the government will not be able to tame its deficit.

Morgan Stanley beats estimates on strong trading

Morgan Stanley's first-quarter results beat expectations, as trading revenue rose sharply and the bank's wealth management business began to improve, sending its shares up in premarket trading on Thursday.

U.S. jobless claims edge down last week

New U.S. claims for unemployment benefits fell less than expected last week, according to a government report on Thursday that could dampen hopes of a pick-up in job creation in April after March's slowdown.

Morgan Stanley loses money on accounting charge

Morgan Stanley lost money during the first quarter because a quirky accounting rule cost the bank $2 billion, but excluding that special item, its earnings rose on stronger wealth-management revenue and cost cutting.

Nokia promises more cost cuts after Q1 loss

Struggling Finnish cellphone maker Nokia promised more, substantial cost cuts and said its sales chief was leaving after reporting a slightly bigger than expected first-quarter loss.

GSK offers $13/share in unsolicited Human Genome bid

Human Genome Sciences Inc said on Thursday its long-time partner GlaxoSmithKline Plc had made an unsolicited proposal to buy it for $13.00 per share in cash, a move underscoring the rapid pace of deal-making in pharmaceuticals.

Spain tests nervous markets with 10-year issue

Spain will pay dearly for longer-term debt on Thursday when it auctions a 10-year bond for only the second time this year to markets spooked by fears it will miss deficit targets and fail to restart growth.

Social media is gold for Olympics advertisers

Advertisers are going for Facebook as athletes go for the gold, in the first Olympic Games where marketers are placing such high hopes on social media to create a buzz for their brands.

Spanish Debt Sale Holds Markets In Check

German bond yields hovered near record lows and the euro held steady on Thursday ahead of bond auctions by Spain and France that are key to investor confidence in Europe's ability to tackle growing economic and fiscal problems.

Judge dismisses claims against banks in GE lawsuit

A federal judge on Wednesday dismissed claims against Goldman Sachs Group Inc , JPMorgan Chase & Co and 40 other defendants that they helped mislead investors in General Electric Co's $12.2 billion stock offering in 2008.

Japan exports jump, but trade still in red; corp mood dips

Japan's exports rose in March from a year earlier for the first time in six months, mainly on the strength of U.S. sales, but high fuel imports pushed the trade balance back into deficit and manufacturers remain cautious about business in months ahead.

Shares mark time ahead of Spanish bond test

Asian shares and the euro traded in tight ranges on Thursday ahead of a Spanish bond sale seen as a key test of investors' risk appetite amid renewed concerns over the euro zone's debt crisis.

Pages